| Literature DB >> 35573988 |
Amin Nozari1, Remi Gagné2, Chunyu Lu1, Carole Yauk1,2, Vance L Trudeau1.
Abstract
Fluoxetine (FLX) and other selective serotonin reuptake inhibitors are widely used to treat depressive disorders during pregnancy. Early-life exposure to FLX is known to disrupt the normal function of the stress axis in humans, rodents, and teleosts. We used a zebrafish line with a cortisol-inducible fluorescent transgene to study the effects of developmental daily exposure to FLX (54 µg/L) on the transcriptomic profile of brain tissues in exposed larvae and later as 6-month-old adults. High throughput RNA sequencing was conducted on brain tissues in unstressed and stressed conditions. Long-lasting effects of FLX were observed in telencephalon (Tel) and hypothalamus (Hyp) of adult zebrafish with 1927 and 5055 genes significantly (≥1.2 fold-change, false-discovery p-value < 0.05) dysregulated in unstressed condition, respectively. Similar findings were observed in Hyp with 1245 and 723 genes being significantly dysregulated in stressed adults, respectively. Differentially expressed genes converted to Homo sapiens orthologues were used for Ingenuity Pathway Analysis. The results showed alteration of pathways involved in neuroendocrine signaling, cholesterol metabolism and synaptogenesis. Enriched networks included lipid metabolism, molecular transport, and nervous system development. Analysis of putative upstream transcription regulators showed potential dysregulation of clocka and nr3c1 which control circadian rhythm, stress response, cholesterol metabolism and histone modifications. Several genes involved in epigenetic regulation were also affected by FLX, including dnmt3a, adarb1, adarb2, hdac4, hdac5, hdac8, and atf2. We report life-long disruptive effects of FLX on pathways associated with neuroendocrine signaling, stress response and the circadian rhythm, and all of which are implicated in the development of depressive disorders in humans. Our results raise concern for the persistent endocrine-disrupting potential of brief antidepressant exposure during embryonic development.Entities:
Keywords: RNA sequencing; brain transcriptome; embryonic development; fluoxetine; life-long effect; zebrafish
Mesh:
Substances:
Year: 2022 PMID: 35573988 PMCID: PMC9097470 DOI: 10.3389/fendo.2022.847322
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Figure 2The effect of developmental fluoxetine exposure on transcriptome patterns in larval and adult male zebrafish central nervous system in the unstressed and stressed conditions. Hierarchical clustering (Spearman correlation) is shown for all 24 samples (stressed, unstressed, fluoxetine-exposed, and control ethanol-exposed) in a single pooled tissue sample (i.e., larval head, hypothalamus, and telencephalon) and their relation to FLX and stress. (A) FLX-exposed larvae compared to the control larvae. (B) telencephalon from adults exposed to FLX in the early life developmental stage compared to control adults exposed to vehicle compound (ethanol) in the early life developmental stage. (C) hypothalamus from adults exposed to FLX in the early life developmental stage compared to control adults exposed to vehicle compound (ethanol) in the early life developmental stage. The Y-axis consists of all genes with significant fold change (FDR ≤0.05 and FC≥ 1.2) in the treatment groups relative to the control groups. The count per million (CPM) of the reads associated with the green fluorescent protein (d4eGFP) transgene in the SR4G zebrafish line is shown. The different shades of green show different CPM. Red: up-regulation, green: down-regulation. Blue: unstressed condition, Lavender: stressed condition, Light Green: control (ethanol), Pink: Fluoxetine.
Figure 1Total numbers of differentially expressed genes (DEGs) in fluoxetine-exposed groups compared to respective controls in unstressed (A) and stressed (B) conditions. The total numbers of DEGs are shown in a stacked format with downregulated and upregulated genes color-coded in green and red, respectively. L, larval head; Tel, telencephalon; Hyp, hypothalamus.
Figure 3Top ten affected canonical pathways following early-life exposure to fluoxetine. The ten pathways with the highest level of significance (i.e. lowest p-value) for each target tissue are shown in larval heads (L), hypothalmus (Hyp), and telencephalon (Tel) in the unstressed (A) and the stressed (B) conditions. The y-axis presents the p-value associated with each pathway on a negative logarithmic scale (-log p-value). The horizontal dash line marks the negative logarithmic value related to the significance level p ≤0.05 [-log10(p)= 1.3]. Each bar shows a canonical pathway identified from the gene cluster enrichment function of IPA. The analysis was performed after converting the gene Ensembl ID of zebrafish (Danio rerio) to human (Homo sapiens) orthologues. Only genes with significant fold change (FC≥1.2; FDR ≤ 0.05) were used for pathway enrichment analysis. (C) The Venn diagram shows the number of all significantly affected pathways in all tissue samples from both the unstressed and the stressed conditions.
Upstream regulators associated with the genes altered by developmental exposure to fluoxetine in zebrafish.
| Upstream regulator | Gene ontology: Biological process | Unstressed | |||||
|---|---|---|---|---|---|---|---|
| L | Hyp | Tel | L | Hyp | Tel | ||
| CLOCK | circadian regulation of gene expression | ||||||
| NPC1 | cholesterol metabolic process | ||||||
| SIRT1 | circadian regulation of gene expression | ||||||
| NFE2L2 | protein catabolic process | ||||||
| RICTOR | TOR signaling | ||||||
| CPT1C | fatty acid beta-oxidation | ||||||
| CCL4 | immune response | ||||||
| PPARD | cholesterol metabolic process | ||||||
| DERL1 | positive regulation of protein binding | ||||||
| NR0B2 | cholesterol metabolic process | ||||||
| PML | circadian regulation of gene expression | ||||||
| GCK | cellular glucose homeostasis | ||||||
| PPARGC1A | circadian regulation of gene expression | ||||||
| SCAP | cholesterol metabolic process | ||||||
| SREBF1 | cholesterol metabolic process | ||||||
| SREBF2 | cholesterol metabolic process | ||||||
| ABCA1 | cholesterol metabolic process | ||||||
| SIRT3 | histone H3 deacetylation | ||||||
| NCOA1 | histone H4 acetylation | ||||||
| STAT3 | negative regulation of neuron death | ||||||
| NR3C1 | stress response | ||||||
| MAT1A | methylation | ||||||
Only significant molecules (p ≤ 0.05) are shown in the blue gradient. Gray represents no significant different from controls. L, larval heads; Hyp, hypothalamus; Tel, telencephalon. Gene ontology is associated with Homo sapiens orthologs.
Top 5 predicted networks affected by developmental exposure to fluoxetine.
| Group | Score | # Genes | Functional clustering* |
|---|---|---|---|
|
| 43 | 35 | Lipid Metabolism, Molecular Transport |
| 14 | 19 | Hepatic System Disease, Liver Steatosis | |
| 13 | 18 | Lipid Metabolism, Molecular Transport | |
| 11 | 17 | Lipid Metabolism, Molecular Transport | |
| 10 | 16 | Lipid Metabolism, Molecular Transport | |
|
| 24 | 35 | Drug Metabolism, Small Molecule Biochemistry |
| 24 | 35 | Lipid Metabolism, Molecular Transport | |
| 24 | 35 | Endocrine System Development and Function | |
| 24 | 35 | Hepatic System Disease, Liver Steatosis | |
| 11 | 26 | Cancer, Gene Expression, Organismal Injury and Abnormalities | |
|
| 34 | 35 | Lipid Metabolism, Small Molecule Biochemistry |
| 34 | 35 | Cellular Development, Cellular Growth and Proliferation | |
| 13 | 16 | Cell Morphology, Cellular Function and Maintenance | |
| 11 | 16 | Cell-To-Cell Signaling and Interaction, Cellular Function and Maintenance | |
| 10 | 19 | Cellular Compromise, Organismal Injury and Abnormalities | |
|
| 29 | 35 | Lipid Metabolism, Molecular Transport |
| 29 | 35 | Lipid Metabolism, Small Molecule Biochemistry | |
| 12 | 16 | Developmental Disorder, Hereditary Disorder, Metabolic Disease | |
| 9 | 21 | Lipid Metabolism, Molecular Transport | |
| 9 | 17 | Behavior, Nervous System Development and Function | |
|
| 12 | 16 | Lipid Metabolism, Molecular Transport |
| 12 | 16 | Lipid Metabolism, Molecular Transport | |
| 12 | 16 | Lipid Metabolism, Molecular Transport | |
| 12 | 16 | Behavior, Nervous System Development and Function | |
| 9 | 14 | Lipid Metabolism, Molecular Transport | |
|
| 11 | 16 | Lipid Metabolism, Behavior, Nervous System Development and Function |
| 11 | 17 | Lipid Metabolism, Small Molecule Biochemistry | |
| 11 | 17 | Lipid Metabolism, Molecular Transport | |
| 11 | 17 | Cellular Development, Tissue Development | |
| 11 | 17 | Metabolic Disease, Organismal Injury and Abnormalities |
*Gene ontology is associated with Homo sapiens orthologs. L, larval heads; Hyp, hypothalamus; Tel, telencephalon.
Figure 4Number of common dysregulated genes in larvae and adult zebrafish upon developmental exposure to fluoxetine in stressed and unstressed conditions. (A) Venn diagram illustrating the common differentially expressed genes between larval heads and adult telencephalon and hypothalamus in the unstressed condition. (B) Venn diagram illustrating the common differentially expressed genes between larval heads and adult telencephalon and hypothalamus in the stressed condition. All of the significantly dysregulated genes (up or downregulated) were included in this comparison (FC≥1.2; p ≤ 0.05). L, larvae; Hyp, hypothalamus; Tel, telencephalon.
Life-long dysregulation of genes involved in epigenetics following developmental exposure to fluoxetine.
| Gene symbole | Unstressed | Stressed | Gene ontology: Biological process* | |||||
|---|---|---|---|---|---|---|---|---|
|
|
| L | Hyp | Tel | L | Hyp | Tel | |
|
|
| Chromatin remodeling | ||||||
|
|
| |||||||
|
|
| |||||||
|
|
| |||||||
|
|
| G2/M transition of mitotic cell cycle | ||||||
|
|
| mRNA processing | ||||||
|
|
| |||||||
|
|
| Negative regulation of transcription from RNA polymerase II promoter | ||||||
|
|
| |||||||
|
|
| |||||||
|
|
| |||||||
|
|
| |||||||
|
|
| Novel protein | ||||||
|
|
| Regulation of postsynaptic membrane potential | ||||||
*Gene ontology is associated with Homo sapiens orthologs. L, larval heads; Hyp, hypothalamus; Tel, telencephalon.
Green, downregulated; Red, upregulated.